Breast cancer screening programs and availability to mammography in Spain;Programas de detección precoz del cáncer de mama y acceso a la mamografía en España

Medicina Clinica

Volumn 108, Issue 20, 1997, Pages 761-766

  Luengo, Setefilla ^a   Azcona, Bárbara ^a   Lázaro, Pablo ^a   Madero, Rosario ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; HEALTH CARE DELIVERY; HUMAN; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRE; SPAIN; STATISTICAL MODEL; TIME;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; SPAIN; TIME FACTORS;

EID: 0000716099     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Ley General de Sanidad (Ley 14/1986 de 25 de abril). Madrid. Ministerio de Sanidad y Consumo, 1987.
2. Aday LA, Andersen R. Marco teórico para el estudio del acceso a la atención médica. En: White KL, editor. Investigaciones sobre servicios de salud: una antologlía. Washington D.C.: Organización Panamericana de la Salud, 1992; 604.
3. Khan AA. Access to health care. Eval Health Prof 1994; 17: 60-76.
4. Clarke KW, Gray D, Keating NA, Hampton JR. Do women with acute myocardial infarction receive the same treatment as men? Br Med J 1994; 309: 563-566.
5. Puentes C. Women and access to health care. Soc Sci Med 1992; 35: 619-626.
6. Kirkman-Liff B, Kronenteld J. Access to cancer screening services for women. Am J Public Health 1992; 82: 733-735.
7. Blarney RW, Wilson ARM, Patnick J, Dixon JM. Screening for breast cancer Br Med J 1994; 309: 1.076-1.079.
8. Rakowski W, Pearlman D, Rimer BK, Ehrich B. Correlates of mammography among women with low and high socioeconomic resources. Prev Med 1995; 24: 149-158.
9. Wright CJ, Barber Mueller C. Screening mammography and public health policy: the need for perspective. Lancet 1995; 346: 29-32.
10. Van Ineveld MV, Van Oortmarsen GJ, De Koning HJ, Boer R, Van der Maas PJ. How cost-effective is breast cancer screening in different EC countries? Eur J Cancer 1993; 29: 1.663-1.668.
11. Constanze ME, D'Orsi C, Greene HL aw VP, Karellas A, Zaptka G. Feasibility o niversal screening mammography. Arch In Med 1991; 151: 1.851-1.856.
12. Katz SJ, Hofer TP. Socioeconomic disp ies in preventive care persist despite universa verage: breast and cervical cancer screening in Ontario and the United States. JAMA 1994; 272: 530-534.
13. Urban N, Anderson GL, Peackok S. Mammography screening: how important is cost as a barrier to use? Am J Public Health 1994; 84: 50-55.
14. Hurley SF, Huggins RM, Jolley DJ, Reading D. Recruitment activities and sociodemographic factors that predict attendance at a mammographic screening program Am J Public Health 1994; 84: 1.655-1.658.
15. Kee F, Telford AM, Donaghy P, O'Doherty A. Attitude or access: reasons for not attending mammography in Northern Ireland. Eur J Cancer Prev 1992; 1: 311-315.
16. Commission of the European Communities. Europeans and the prevention of cancer. A public opinion survey. En: Europe against cancer. A working document of the services of the European Commission. Londres: Commission of the European Communities, 1987.
17. Rodríguez C, Plasencia A, Schroeder DG. Predictive factors of enrollment and adherence in a breast cancer screening program in Barcelona (Spain). Soc Sci Med 1995; 40: 1.155-1.160.
18. Ascunce N, Del Moral A, Murillo A, Alfaro C, Apesteguía L, Ros J et al. Early detection programme for breast cancer in Navarra, Spain. Eur J Cancer Prev 1994; 3 (Supl 1): 41-48.
19. Bonfill X, Marzo M, Medina C, Roura P, Rué M. L'efectivitat del cribatge del càncer de mama en el nostre entorn. Gac Sanit 1992; 6: 128-142.
20. Robinson J, Athnasiou R, Head K. Measures of occupational attitudes and occupational characteristics. Ann Arbor: Michigan University Press, 1969.
21. Informe Económico 1993 BBV (Banco Bilbao Vizcaya), Bilbao: Servicio de Estudios, 1993.
22. Programa de prevención del cáncer de mama. Valladolid: Junta de Castilla y León, Consejeria de Sanidad y Bienestar Social, 1993.
23. Campaña prevención cáncer de mama: campaña realizada en la comunidad de Madrid 1992-1993. Madrid: Asociación Española Contra el Cáncer, 1994.
24. Programa de prevención de cáncer de mama: resultados 1994. Informes de Salud n.o 20. Conselleria de Sanitat i Consum. Valencia: Generalitat Valenciana, Direcció General de Salut Pública, 1995.
25. Rodriguez Sarmiento C, Plasencia Taradach A, Ferrer Masip F, Gómez Gómez A. Programa PAM de detección temprana de cáncer de mama: primeros resultados (1987-1990). Med Clin (Barc) 1991; 96: 206-210.
26. Almazán C, Borrás JM, De la Puente ML, Giménez A, Granados A. Aproximación a la utilización de la mamografia de cribado en dos regiones sanitarias. Aten Primaria 1995; 15: 452-456.
27. Mooney GH. Just health care: only medicine? En: Economics, medicine and health care. Londres: Harvester Wheastsheaf, 1986; 107.
28. Culyer AJ. The morality of efficiency in health care: some uncomfortable implications. Health Econ 1992; 1: 7-18.
29. Lázaro P. Evaluación de tecnología médica. Monografías de Economía y Gestión Sanitaria. Pap Gest Sanit. Valencia: MICIQ, 1994; 59.
30. Nutting PA, Calonge BN, Iverson DC, Green LA. The danger of applying uniform clinical policies across populations: the case of breast cancer in American Indians, Am J Public Health 1994; 84: 1.631- 1.636.
31. Glasse L. Breast cancer screening in older women: the consumer perspective. J Gerontol 1992; 47: 137-141.
32. Borrás JM, Ciurana R, Marzo M. Cribado del cáncer de mama. Med Clin (Barc) 1994; 102 (Supl 1): 75-79.
33. Kerlikowshe K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a metaanalysis. JAMA 1995; 273: 149-154.
34. White E, Urban N, Taylor V. Mammography utilization, public health impact, and cost-effectiveness in the United States. Annu Rev Public Health 1993; 14: 605-633.
35. Campbell H, Mackay J, Porteus M. The future of breast and ovarian cancer clinics. Br Med J 1995; 311: 1.584-1.585.
36. Breen N, Keesler L. Changes in the use of screening mammography: evidence from the 1987 and 1990 national health interview surveys. Am J Public Health 1994; 84: 62-67.
37. Pearson V, Parkinson M. Breast screening, health promotion and empowerment: the district's dilemma. Health Educ J 1994; 53: 282-290.
38. Whitehead M. The concepts and principles of equity and health. Int J Health Serv 1992; 22: 429-445.
39. Rice DP. Ethics and equity in US health care: the data. Int J Health Serv 1991; 21: 637-651
40. Bonfill X, Marzo M, Medina C, Roura P. Diagnóstico temprano del cáncer de mama. Med Clin (Barc) 1992; 99: 797.
41. Donovan D, Middleton J, Ellis D. Early detection of breast cancer. Lancet 1988; 1: 685.
42. Rimer BK, Rech N, King E, Ross E, Lerman C, Boyce A et al. Multistrategy health education program to increase mammography use among women ages 65 and older. Public Health Rep 1992; 107: 369-380.
43. Fulton JP, Rakowski W, Jones AC. Determinants of breast cancer screening among inner-city Hispanic women in comparison with other inner-city women. Public Health Rep 1995; 110: 476-482.
44. Fox SA, Kimme-Smith C, Klos DS. The technology of mammography. Int J Technol Assess Health Care 1988; 4: 521-544.
45. Barnadas A. Diagnóstico temprano del cáncer de mama. Med Clin (Barc) 1992; 98: 297-299.
46. Friedman LC, Woodfruff A, Lane M, Weinberg AD, Cooper HP, Webb JA, Breast cancer screning behaviors and intentions among asymptomatic women 50 years of age and older. Am J Prev Med 1995; 11: 218-223.